Income Statement
ONCONETIX, INC.
ONCO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
0.82 | 2.52 | 0.06 | - |
|
Cost of Revenue
|
0.46 | 1.47 | 1.19 | - |
|
Gross Profit
|
0.63 | 1.06 | -1.13 | - |
|
Operating Expenses
|
18.49 | 57.54 | 34.91 | 13.48 |
|
Research & Development
|
- | 0.15 | 1.95 | 4.13 |
|
Selling, General & Administrative
|
7.04 | 11.23 | 14.77 | 9.35 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-17.86 | -56.49 | -36.03 | -13.48 |
|
Non-Operating Income
|
3.83 | -3.25 | - | - |
|
Interest Income
|
0.00 | 0.00 | - | - |
|
Interest Expense
|
0.80 | - | 0.70 | - |
|
Other Non-Op Income / Expense
|
0.23 | 0.17 | -1.39 | - |
|
Income Before Tax
|
-14.03 | -59.74 | -37.42 | - |
|
Income Tax Expense
|
0.00 | -1.05 | -0.01 | - |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
28.06 | -58.69 | 0.32 | -13.42 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-17.84 | -55.76 | -35.99 | -13.48 |
|
Earnings Per Share (Basic)
|
-16.56 | -21.45 | -2.19 | -1.10 |
|
Diluted EPS
|
-16.56 | -21.45 | - | - |
|
Weighted Average Shares
|
0.94 | 2.75 | 17.11 | 12.27 |
|
Diluted Weighted Avg Shares
|
0.94 | 2.75 | - | - |
|
Comprehensive Income
|
-11.20 | -63.80 | -35.03 | - |